A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of D-2570 in the treatment of active systemic lupus erythematosus.

Timeline

Start

2026-02-12

Primary completion

2028-08-31

Completion

2028-12-31

Drugs

Indications